Stock Earnings

Question 1

What are Carisma Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Carisma Therapeutics Inc has a total asset of $30, Net loss of $-60

Question 2

What are the key financial ratios for CARM?

Accepted Answer

Carisma Therapeutics Inc's Current ratio is 0.51, has a Net margin is -315.78, sales per share of $0.45.

Question 3

How is Carisma Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Carisma Therapeutics Inc largest revenue segment is Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy, at a revenue of 19,632,000 in the most earnings release.For geography, United States is the primary market for Carisma Therapeutics Inc, at a revenue of 19,632,000.

Question 4

Is Carisma Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Carisma Therapeutics Inc has a net loss of $-60

Question 5

Does Carisma Therapeutics Inc have any liabilities?

Accepted Answer

yes, Carisma Therapeutics Inc has liability of 58

Question 6

How many outstanding shares for Carisma Therapeutics Inc?

Accepted Answer

Carisma Therapeutics Inc has a total outstanding shares of 41.75

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10	19	14	40	26	11
Revenue Growth (YoY)	-50%	36%	-65%	54%	136%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	18	22	29	39	29	14
Research & Development	38	59	74	38	25	29
Operating Expenses	56	81	103	26	-2	32
Other Non Operating Income (Expenses)	1	--	--	0	0	0
Pretax Income	-49	-60	-86	-23	-8	-20
Income Tax Expense	0	--	--	-3	-8	1
Net Income	-49	-60	-86	-19	0	-22
Net Income Growth	-32%	-30%	353%	--	-100%	-79%
Shares Outstanding (Diluted)	41.78	41.45	33.52	10.03	9.12	5.91
Shares Change (YoY)	1%	24%	234%	10%	54%	30%
EPS (Diluted)	-1.18	-1.45	-2.59	-1.98	-0.04	-3.81
EPS Growth	-32%	-44%	31%	4,850%	-99%	-84%
Free Cash Flow	-37	-60	-82	24	-68	-30
Free Cash Flow Per Share	-0.88	-1.44	-2.44	2.39	-7.45	-5.07
Gross Margin	--	--	--	--	--	--
Operating Margin	-459.99%	-326.31%	-628.57%	32.5%	107.69%	-190.9%
Profit Margin	-490%	-315.78%	-614.28%	-47.5%	0%	-200%
Free Cash Flow Margin	-370%	-315.78%	-585.71%	60%	-261.53%	-272.72%
EBITDA	-44	-59	-86	13	28	-21
EBITDA Margin	-440%	-310.52%	-614.28%	32.5%	107.69%	-190.9%
D&A For EBITDA	2	3	2	0	0	0
EBIT	-46	-62	-88	13	28	-21
EBIT Margin	-459.99%	-326.31%	-628.57%	32.5%	107.69%	-190.9%
Effective Tax Rate	0%	--	--	13.04%	100%	-5%

Carisma Therapeutics Inc (CARM) Price

CARM Stock Price Chart

CARM Income

Follow-Up Questions